*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

SERETIDE

Fluticasone Propionate; Salmeterol (Salmeterol Xinafoate)
125 mcg; 25 mcg
Inhalation powder

ROA

Inhalation, Oral

Applicant Name

GlaxoSmithKline Pharmaceutical Nig. PLC (GSK)

NRN

04-6850

Status

Active


ATC Code

R03AK06  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 X 120 actuations  

Product Description

25 RNW-PP-310050 SERETIDE 25MCG SALMETEROL/ 125MCG FLUTICASONE PROPIONATE Salmeterol xinafoate equivalent to 25 micrograms of salmeterol and 125 micrograms of fluticasone propionate Apr-50 Drugs Imported Products 1*120actuations POM 1 2/1/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 delphine.u.onyeaso@gsk.com GLAXO WELLCOME PRODUCTION, ZONE INDUSTRIELLE No 2, 23, RUE LAVOISIER 27000 EVREUSX FRANCE, France

Manufacturer Name

Glaxo Wellcome Production

Manufacturer Country

FRANCE  

Approval Date

2023-05-25  

Expiry Date

2028-05-24